Scientific news

First cannabis-derived drug is on the verge of US approval

Approval of the medication, intended for childhood epilepsy, could lead to reclassification of cannabidiol

Study compares cannabis benefits for patients with chronic pain and migraine

For many patients with migraine, cannabis served as a substitute for other pain medications, including opioids

What is cannabis oil and how does it work?

Your questions about the medical use of cannabis oil answered

Cannabidiol shows promise alongside conventional epilepsy medication in Lennox-Gastaut syndrome

Last month, a study was published in the New England Journal of Medicine on the results of a clinical trial of the effects of cannabidiol on drop seizures in Lennox-Gastaut syndrome

Canopy Growth donates $2.5 million for opioid addiction research

One of the largest cannabis cultivators in Canada is helping to address the nation’s overdose crisis

UN Review may lead WHO to reschedule cannabis

The UN’s World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) will review and assess the medical uses and harms of Cannabis on June 4-7 to recommend the most appropriate classification to be applied internationally

Medical cannabis and the challenge for regulation of medicines in the UK

Medical cannabis challenges scientific norms and the usual regulation of medicines.

Israeli companies get 'foot in the door' of US medical industry

Thomas Jefferson University launches global centre in Jerusalem

LAU to study 'potential medical value' of marijuana in Lebanon

The Lebanese American University is set to launch an independent research center dedicated to studying the health effects and potential economic gains of medical marijuana in Lebanon.

Cannabis may help children with complex movement disorders

Cannabis may be able to help yet another group of patients improve their quality of life; this time it is a group of kids in need of some good news.